Tilman Otto
- Ophthalmology top 2%
- Retinal Diseases and Treatments 9
- Glaucoma and retinal disorders 8
- Retinal and Optic Conditions 2
-
- Retinal Imaging and Analysis 7
- Retinal and Macular Surgery 3
-
- Retinal Development and Disorders 2
-
- Optical Coherence Tomography Applications 4
-
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Hans E. VölckerC. BellmannFrank G. HolzF. SchüttDirk‐Uwe BartschRichard F. SpaideWilliam R. FreemanPeter M. Maloca
- Journals
- Der Ophthalmologe (2 papers)Investigative Ophthalmology & Visual Science (2 papers)Retina (2 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Tilman Otto
12 papers receiving 312 citations
Peers
Comparison fields: 5 of 36
- Ophthalmology 289
- Radiology, Nuclear Medicine and Imaging 151
- Molecular Biology 148
- Biochemistry 10
- Clinical Biochemistry 6
Countries citing papers authored by Tilman Otto
This map shows the geographic impact of Tilman Otto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilman Otto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilman Otto more than expected).
Fields of papers citing papers by Tilman Otto
This network shows the impact of papers produced by Tilman Otto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilman Otto. The network helps show where Tilman Otto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tilman Otto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 12 | |
| 4 | 2022 | 8 | |
| 5 | 2021 | 6 | |
| 6 | 2020 | 3 | |
| 7 | 2019 | 6 | |
| 8 | 2004 | 6 | |
| 9 | 2000 | 3 | |
| 10 | 1999 | 205 | |
| 11 | 1999 | 21 | |
| 12 | 1997 | 49 | |
| 13 | 1994 | 0 |
About Tilman Otto
Tilman Otto is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Biomedical Engineering, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 324 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (9 papers), Glaucoma and retinal disorders (8 papers), Retinal Imaging and Analysis (7 papers), Optical Coherence Tomography Applications (4 papers), Retinal and Macular Surgery (3 papers), Retinal and Optic Conditions (2 papers), Retinal Development and Disorders (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Ophthalmology (289 citations), Radiology, Nuclear Medicine and Imaging (151 citations), Molecular Biology (148 citations), Biochemistry (10 citations) and Clinical Biochemistry (6 citations). Tilman Otto has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Hans E. Völcker, C. Bellmann, Frank G. Holz, F. Schütt, Dirk‐Uwe Bartsch, Richard F. Spaide, William R. Freeman, Peter M. Maloca, Hendrik P. N. Scholl and Martin S. Zinkernagel. Their work appears in journals such as Der Ophthalmologe, Investigative Ophthalmology & Visual Science, Retina, Ophthalmic Research and Translational Vision Science & Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.